We have seen an unprecedented rise in NYSE:ACB in the past days (216% since Thursday 5/14). This made the stock be close to the higher limit of top analysts targets. If we take a closer look into the ACB's fundamentals and financial conditions, we expect the stock to go short in the next months. There is low support for such a high rise at the moment, as the stock is at highest levels since February, on the other side there are signs the current valuation is over the realistic financial conditions.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp-related food products.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。